RxDoctor Payments Data

James Gould, MD

Otolaryngology · Festus, MONPI 1912908161

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $137,063 of the $143,463 with a category attached, or 95.5%. Stryker accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $57,387 and has fallen 98.8% since, to $703 in 2025. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$143,463in general payments, 2019–2025

Across 138 payments — averaging $1039.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$143K
  • Neurent Medical Limited$169
  • KARL Storz Endoscopy-america$114
  • Acclarent, Inc$102
  • Amgen$48
  • Greer Laboratories, Inc.$19

What the payments were for

  • Consulting fees$137,06396%
  • Travel & lodging$2,4262%
  • Food & beverage$3,9403%
  • Education$340%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker130$143,012
Neurent Medical Limited1$169
KARL Storz Endoscopy-america3$114
Acclarent, Inc1$102
Amgen2$48
Greer Laboratories, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$143,463 in reported general payments places this provider in the 95th percentile of 210 otolaryngology providers in Missouri.

See all otolaryngology providers in Missouri

Medicare billing

Part B allowed, 2024
$878,743
Medicare patients
239
Services billed
1,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine51$7,932
Ipratropium Bromide47$2,478
Mupirocin253$2,340
Triamcinolone Acetonide244$1,420
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,236
Montelukast Sodium113$779
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort11$643
Levocetirizine Dihydrochloride40$469
Azelastine Hcl24$407
Levothyroxine Sodium15$179
Fluticasone Propionate14$171
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$29
Prednisone13$25

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Festus

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →